CarboCode is a series c plus startup. 1 investor tracked. Status: possibledead.
Based in Portugal, CarboCode is a startup founded in 2017. Its most recent tracked round is Series-c-plus. Brouky records 1 investor associated with the company.
CarboCode develops and produces human-identical glycosphingolipids and gangliosides, which are vital components found in breast milk and organ membranes, for applications in infant nutrition, dermatology, and cognitive health.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.